BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 19204086)

  • 1. c-Jun N-terminal kinase 1 phosphorylates Myt1 to prevent UVA-induced skin cancer.
    Choi HS; Bode AM; Shim JH; Lee SY; Dong Z
    Mol Cell Biol; 2009 Apr; 29(8):2168-80. PubMed ID: 19204086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis.
    Liu J; Minemoto Y; Lin A
    Mol Cell Biol; 2004 Dec; 24(24):10844-56. PubMed ID: 15572687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiapoptotic effect of c-Jun N-terminal Kinase-1 through Mcl-1 stabilization in TNF-induced hepatocyte apoptosis.
    Kodama Y; Taura K; Miura K; Schnabl B; Osawa Y; Brenner DA
    Gastroenterology; 2009 Apr; 136(4):1423-34. PubMed ID: 19249395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor-induced toxic liver injury results from JNK2-dependent activation of caspase-8 and the mitochondrial death pathway.
    Wang Y; Singh R; Lefkowitch JH; Rigoli RM; Czaja MJ
    J Biol Chem; 2006 Jun; 281(22):15258-67. PubMed ID: 16571730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coordination of JNK1 and JNK2 is critical for GADD45alpha induction and its mediated cell apoptosis in arsenite responses.
    Zhang D; Song L; Li J; Wu K; Huang C
    J Biol Chem; 2006 Nov; 281(45):34113-23. PubMed ID: 16973625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation.
    Sabapathy K; Hochedlinger K; Nam SY; Bauer A; Karin M; Wagner EF
    Mol Cell; 2004 Sep; 15(5):713-25. PubMed ID: 15350216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arsenic trioxide induces apoptosis through JNK and ERK in human mesothelioma cells.
    Eguchi R; Fujimori Y; Takeda H; Tabata C; Ohta T; Kuribayashi K; Fukuoka K; Nakano T
    J Cell Physiol; 2011 Mar; 226(3):762-8. PubMed ID: 20799280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for c-Jun N-terminal kinase 1 (JNK1), but not JNK2, in the beta-amyloid-mediated stabilization of protein p53 and induction of the apoptotic cascade in cultured cortical neurons.
    Fogarty MP; Downer EJ; Campbell V
    Biochem J; 2003 May; 371(Pt 3):789-98. PubMed ID: 12534344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoform-specific functions of c-Jun N-terminal kinase 1 and 2 in lung ischemia-reperfusion injury through the c-Jun/activator protein-1 pathway.
    Tan J; Gao W; Yang W; Zeng X; Wang L; Cui X
    J Thorac Cardiovasc Surg; 2021 Aug; 162(2):e143-e156. PubMed ID: 32414595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal cancer cell survival involves JNK2 suppression of a novel JNK1/c-Jun/Bcl-3 apoptotic network.
    Ahmed SU; Milner J
    PLoS One; 2009 Oct; 4(10):e7305. PubMed ID: 19806201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of JNK1 and JNK2 on signal specific induction of apoptosis.
    Hochedlinger K; Wagner EF; Sabapathy K
    Oncogene; 2002 Apr; 21(15):2441-5. PubMed ID: 11948429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the c-jun N-terminal kinases JNK1 and JNK2 in complement-mediated cell death.
    Gancz D; Donin N; Fishelson Z
    Mol Immunol; 2009 Dec; 47(2-3):310-7. PubMed ID: 19864026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Jnk1 Deficiency in Hematopoietic Cells Suppresses Macrophage Apoptosis and Increases Atherosclerosis in Low-Density Lipoprotein Receptor Null Mice.
    Babaev VR; Yeung M; Erbay E; Ding L; Zhang Y; May JM; Fazio S; Hotamisligil GS; Linton MF
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1122-31. PubMed ID: 27102962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined Activities of JNK1 and JNK2 in Hepatocytes Protect Against Toxic Liver Injury.
    Cubero FJ; Zoubek ME; Hu W; Peng J; Zhao G; Nevzorova YA; Al Masaoudi M; Bechmann LP; Boekschoten MV; Muller M; Preisinger C; Gassler N; Canbay AE; Luedde T; Davis RJ; Liedtke C; Trautwein C
    Gastroenterology; 2016 Apr; 150(4):968-81. PubMed ID: 26708719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatotoxicity mediated by pyrazole (cytochrome P450 2E1) plus tumor necrosis factor alpha treatment occurs in c-Jun N-terminal kinase 2-/- but not in c-Jun N-terminal kinase 1-/- mice.
    Wang X; Wu D; Yang L; Cederbaum AI
    Hepatology; 2011 Nov; 54(5):1753-66. PubMed ID: 21748763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Licochalcone A, a natural inhibitor of c-Jun N-terminal kinase 1.
    Yao K; Chen H; Lee MH; Li H; Ma W; Peng C; Song NR; Lee KW; Bode AM; Dong Z; Dong Z
    Cancer Prev Res (Phila); 2014 Jan; 7(1):139-49. PubMed ID: 24253317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-JUN N-terminal kinase-1 (JNK1) but not JNK2 or JNK3 is involved in UV signal transduction in human epidermis.
    Katagiri C; Negishi K; Hibino T
    J Dermatol Sci; 2006 Sep; 43(3):171-9. PubMed ID: 16824735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential transmission of MEKK1 morphogenetic signals by JNK1 and JNK2.
    Takatori A; Geh E; Chen L; Zhang L; Meller J; Xia Y
    Development; 2008 Jan; 135(1):23-32. PubMed ID: 18032450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Jun NH2-terminal kinase (JNK)1 and JNK2 have similar and stage-dependent roles in regulating T cell apoptosis and proliferation.
    Sabapathy K; Kallunki T; David JP; Graef I; Karin M; Wagner EF
    J Exp Med; 2001 Feb; 193(3):317-28. PubMed ID: 11157052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JNK2 Is Required for the Tumorigenic Properties of Melanoma Cells.
    Du L; Anderson A; Nguyen K; Ojeda SS; Ortiz-Rivera I; Nguyen TN; Zhang T; Kaoud TS; Gray NS; Dalby KN; Tsai KY
    ACS Chem Biol; 2019 Jul; 14(7):1426-1435. PubMed ID: 31063355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.